Meridian Clinical Research
Acquisition in 2022
Meridian Clinical Research is a multi-specialty network focused on facilitating clinical trials for pharmaceutical and biotechnology companies. The organization conducts studies across phases 1 to 4, covering a wide range of therapeutic areas. It is particularly noted for its expertise in high-volume vaccine trials, which plays a crucial role in the development of new drugs, medical devices, and diagnostic tools. By providing comprehensive clinical research services, Meridian Clinical Research supports the advancement of medical innovations aimed at enhancing human health and well-being.
Egin Research
Acquisition in 2022
Egin Research is an operator of a global network of dedicated clinical research centers that cater to pharmaceutical companies. The company specializes in conducting clinical trials across various therapeutic areas, including autoimmune diseases, respiratory conditions, and internal medicine, such as diabetes and dermatology. By focusing on these diverse fields, Egin Research aims to facilitate the safe and accurate execution of clinical trials, ensuring that pharmaceutical companies receive reliable data for their drug development processes. This comprehensive approach positions Egin Research as a key player in advancing medical research and improving health outcomes worldwide.
MedPharmics
Acquisition in 2022
MedPharmics is a clinical research center dedicated to assessing the efficacy and safety of medications through comprehensive clinical trials. The organization specializes in a variety of fields, including primary care, women's health, vaccines, and pediatric research. By ensuring rigorous trial management, MedPharmics supports its clients in upholding high standards of care throughout the clinical development process. This focus on quality enables the company to provide reliable and valuable insights that contribute to the advancement of healthcare solutions.
Clinical Research Hamburg
Acquisition in 2022
Clinical Research Hamburg is an outpatient test center for clinical research phases II, III and IV.
Trier Health
Acquisition in 2022
Trier Health operates a digital clinical trials platform called DeepCentric, designed to enhance patient experience and improve the efficiency of clinical trial execution. The platform facilitates both hybrid and fully decentralized trials, placing the patient at the core of the process. By leveraging advanced analytics and artificial intelligence, DeepCentric enriches collaboration between patients and clinicians while enhancing patient engagement. Trier Health emphasizes data security through biometric authentication and a blockchain framework, ensuring controlled access and protecting sensitive information. The company's innovative approach aims to transform the delivery of healthcare, ultimately improving care quality and operational efficiencies in clinical trials.
Riverside Clinical Research
Acquisition in 2021
Riverside Clinical Research is a company that specializes in clinical research trials.
Downtown Women's Health Care
Acquisition in 2021
Downtown Women's Health Care is a private clinic focused on providing specialized women's health care and conducting gynecological clinical research. The clinic prioritizes women's health studies, with particular emphasis on conditions such as endometriosis, birth control, and research related to hot flashes. By combining clinical care with research initiatives, Downtown Women's Health Care aims to enhance the understanding and treatment of women's health issues, thereby contributing to improved patient outcomes and advancements in the field.
eStudySite
Acquisition in 2020
eStudySite, Inc. is a clinical research organization based in La Mesa, California, with an additional location in Las Vegas, Nevada. Founded in 1999, the company specializes in conducting Phase II and Phase III clinical trials across various therapeutic areas, including endocrinology, hepatology, dermatology, gastroenterology, and infectious diseases. Its research covers a broad range of conditions such as NASH/NALFD, Type 2 diabetes, anemia, inflammatory bowel diseases, and women's health issues. eStudySite also offers a proprietary software solution designed to manage a diverse database of participants, enhancing its ability to conduct studies effectively. As of November 2020, eStudySite operates as a subsidiary of VCR Holdings, LLC.
Rapid Medical Research
Acquisition in 2019
Rapid Medical Research is an independent research center specializing in conducting Phase I-IV clinical trials. The company operates as a progressive clinical trials management organization, providing essential data collection services to the medical community. Through its clinical research efforts, Rapid Medical Research aims to enhance the understanding of disease mechanisms and contribute to advancements in medical knowledge.
Advanced Clinical Research
Acquisition in 2019
Advanced Clinical Research is a progressive Clinical Trials Management Organization that specializes in multi-therapeutic clinical research. The company is dedicated to providing superior services and ensuring high-quality data collection for the medical community. By focusing on clinical research, Advanced Clinical Research enhances the understanding of disease mechanisms, contributing valuable insights to the field of medicine.